Recently Featured

Sanofi Under Antitrust Probe as European Commission Kicks Off Formal Proceedings

July 13, 2026
The European Commission has initiated formal antitrust proceedings against Sanofi, focusing on the company’s marketing practices related to its flu vaccine, Efluelda, intended for at-risk seniors. This investigation marks a significant step in regulatory scrutiny within the pharmaceutical sector, particularly concerning how major players promote essential healthcare products. Contextually, the probe reflects growing concerns among…

FDA Slaps Dr. Reddy’s Hyderabad Biologics Plant with Seven Observations in New Form 483

July 13, 2026
The U.S. Food and Drug Administration (FDA) has issued a Form 483 to Dr. Reddy’s Laboratories, citing seven observations at its biologics manufacturing facility in Bachupally, Hyderabad, following an inspection conducted in mid-June. These observations are critical as they highlight potential compliance issues that could impact the plant’s operational capabilities and product quality. Contextually, the…

FDA Releases Guidance on Medical Product Communications Aligned with Required Labeling

July 13, 2026
The FDA has issued new guidance for industry regarding medical product communications that must align with FDA-required labeling. This document aims to clarify how companies can communicate effectively while remaining compliant with regulatory standards. As the landscape of pharmaceutical communications evolves, the FDA’s emphasis on consistency with approved labeling is critical for maintaining transparency and…

Europe’s CHMP Reverses Endorsement of Tavneos as Amgen FDA Hearing Looms

July 12, 2026
Amgen faces a significant challenge as the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the withdrawal of its endorsement for Tavneos, a treatment for ANCA-associated vasculitis. This decision stems from a recent review indicating that the drug’s benefits no longer outweigh its associated risks. Such a reversal marks a…

Ongoing Cases